Opthea Ltd. (OPT.AX,OPT), a clinical-stage biopharmaceutical company, Monday announced the appointment of Hamish George as Chief Financial Officer, effective today.
The company also stated that Stephanie Vipond of Bio101 will assume the role of Joint Company Secretary in place of Karen Adams, effective today.
Together, George and Vipond are responsible for communication between the Company and ASX.
In the pre-market activity, shares are trading at $3.41 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.